Featured Portfolio
It is well known that ventral hernia surgical meshes can cause complications, often catastrophic. XyberCyl presents a truly complication-free ventral hernia repair. XyberCyl’s monofilament silicone with its patented wide-open spaces will not cause irritation (no foreign body reaction), and creates a setting where the body’s capabilities for natural healing are fully realized, while thus providing a complication-free, permanent repair of the ventral hernia defect. XyberCyl truly creates and maintains an environment wherein the body can heal itself. |
TOP STORIES
PATENTS AND TECHNOLOGY
Titan Medical Inc. Explores New Horizons in Robotic Surgery with Expansive Patent Portfolio
by BNN Breaking in March ‘24
Titan Medical Inc. leverages its patent portfolio to advance robotic assisted surgery, setting new standards in medical technology and patient care.
Researchers use 3D-printed skin to close wounds
by VoxelMatters in March ‘24
Researchers use 3D printed skin, containing hair follicle precursors, to close wounds and advance reconstructive surgery.
Defence Therapeutics Awarded Broad U.S. Patent Covering Its Pioneering Cancer-Killing AccuTOX(R) Technology
by Yahoo Finance in March ‘24
The ‘350 patent, which includes valuable composition-of-matter claims covering a portfolio of therapeutically-active molecules making up the AccuTOX® platform, provides Defence with potential market exclusivity until late 2042.
TOP STORIES
HEALTHCARE TRANSACTIONS
Progenics says MIM stole its tech to woo GE HealthCare into acquiring it
by DOTmed in March ‘24
Progenics Pharmaceuticals, a biopharmaceutical company, has accused radiology AI solution maker MIM Software of using its patented technology to secure an acquisition from GE HealthCare. |
Medtronic accuses Axonics of patent infringement, files ITC complaint
by MSN in March ‘24
RECENTLY
ISSUED PATENTS
Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
by Chronicle-Tribune in March ‘24
Patent and CA8* gene therapy technology licensed by Adolore BioTherapeutics from the University of Miami.
Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
by Business Wire in March ‘24
Therapeutic Solutions International, Inc. (TSOI), a clinical-stage stem cell and immunotherapy company, announced today the granting of a patent cover.
Axonics Secures Patent for Innovative Neurostimulator Programming Training System
by BNN Breaking in March ‘24
Discover Axonics’s groundbreaking neurostimulator programming training system, a patented innovation enhancing clinician training and patient care. |
CURRENT PORTFOLIO AVAILABLE
FOR SALE
AND LICENSE WITH HIGH INTEREST
Picture this: an automated gown-donning machine that zips through tasks with precision, guaranteeing both efficiency and top-notch infection control. Then, there’s the incredibly versatile surgical gown, available in sterile and non-sterile options, designed to wrap you in comfort and resilience.
